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Abstract
Background: The Dutch government has set targets for reduction of antimicrobial usage in food animals, stipulating a
50% reduction in usage (on a weight basis) in 2013 as compared to 2009 and a 70% decrease in 2015. A monitoring
program has been instituted to evaluate the impact on antimicrobial resistance (AMR). The Dutch Ministry of Public
Health Welfare and Sports has expressed the need for a summary index to present the results of the monitoring data
concisely to policy makers.
Methods: We use data on AMR in bacteria from randomly collected samples from broiler chickens, fattening pigs, veal
calves and dairy cows. Escherichia coli was selected for resistance monitoring because they are intrinsically susceptible
to the antibiotics included in the test panel (ciprofloxacin, cefotaxime, tetracycline and ampicillin) and they are present
in all samples, which facilitates proper randomization and trend analysis. The AMR summary index was calculated for
each animal species as a weighted average over the four antibiotics, taking into account their clinical relevance.
Weights were obtained by conjoint analysis, a pairwise comparison study involving infectious diseases professionals
with clinical and public health backgrounds, with data analysis by conditional logistic regression. The AMR summary
index was then computed by Monte Carlo simulation, accounting for sampling and regression uncertainty.
Results: The highest weights (0.35) were given to ciprofloxacin and cefotaxime followed by ampicillin (0.23) and
tetracycline (0.07). Throughout the years, the AMR index was highest in broiler chickens, followed by pigs and veal
calves, while the lowest values were consistently recorded in dairy cows. In all animal species, the index in 2014 was
significantly lower than in 2009.
Conclusions: We demonstrate that high-dimensional data on surveillance of antimicrobial resistance can be
summarized in an index for evaluating trends between and within food animal species by a process involving decision
makers and scientists to select and weight the most relevant antibiotics.
Introduction
Historically, antimicrobial usage in food animals in the
Netherlands was high compared to many other industri-
alized countries [1]. This high usage caused increasing
concern because of increasing trends in antimicrobial
resistance (AMR) among pathogens and commensal bac-
teria isolated from food animals. The Dutch government
has set targets for reduction of antimicrobial usage in
food animals, stipulating a 50% reduction in usage (on a
weight basis) in 2013 as compared to 2009 and a 70%
decrease in 2015 compared to 2009. In order to achieve
this goal, benchmark thresholds for veterinary anti-
microbial use on individual livestock farms were decided
upon in 2011 by the Netherlands Veterinary Medicines
Authority [2]. Antimicrobial usage and AMR are annu-
ally reported in the MARAN series of reports, a joint
publication by the Central Veterinary Institute, the
Netherlands Veterinary Medicines Authority, Utrecht
University, the Dutch Food and Consumer Safety
Authority, and the National Institute for Public Health
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and the Environment. Indeed, antimicrobial usage in
food animals has decreased from 495 t active substance
in 2009 to 217 t in 2013, a decrease of 56% and meeting
the target set by government. The decrease was observed
in all major food animal species. In 2014, the decrease
levelled off, and total sales were 58% below the level of 2009
[1]. Figure 1 shows the time trend of sales of antimicrobial
licensed for therapeutic use in the Netherlands, by pharma-
cotherapeutic group. Sales data show the largest decrease
for tetracyclines (73% reduction from 2009 to 2014),
although it still was the most used group in 2014. Penicillins
(betal-actams) were the second most applied group, sales
being reduced 34% between 2009 and 2014.
To evaluate the impact of the reduction in antimicrobial
usage on antimicrobial resistance in food animals, a
monitoring program has been instituted, in which several
pathogenic bacteria (including Salmonella enterica,
Campylobacter spp. and Shiga-toxin producing Escherichia
coli) and commensal bacteria (including Escherichia coli and
Enterococcus spp.) are included. Food animals as well as
foods of animal and non-animal origin are sampled and iso-
lates are subjected to resistance testing by several laborator-
ies, using standardized protocols [3].
The MARAN series of reports offer a comprehensive over-
view of all AMR monitoring data. However, the level of detail
in these reports is difficult to communicate to policy makers
and Parliament. Therefore, the Dutch Ministry of Public
Health Welfare and Sports has expressed the need for a
summary index of antimicrobial resistance in food, in order
to report the impact of reducing antibiotics use in food ani-
mals on AMR in food-related isolates. Such an index should
be presented annually, starting with data from 2009; the base
year for the Dutch reduction policy for antibiotics use.
To our knowledge, such a summary index has not
been presented before. Aggregating data on antimicro-
bial resistance requires many choices to be made. These
choices involve both scientific and policy aspects.
Therefore, an interactive process involving different
stakeholders was needed to arrive at a result that is
useful for decision-making. This paper describes the
construction of such a summary index, documenting the
available data, the process to make scientific and policy
choices that needed to be made for data aggregation,
and presents results up to 2014.
Methods
Selection of micro-organisms and antibiotics
A workshop involving policy makers, scientists, veterinarians
and medical doctors defined priorities for selection of micro-
organisms and antibiotics, and evaluated the currently avail-
able monitoring systems. A preliminary selection of the pri-
ority micro-organisms and antimicrobial agents was based
on an earlier published risk profile [4]. The selection included
critically important antibiotics as defined by the World
Health Organization and the World Organization for Animal
Health (3rd/4th generation cephalosporins and fluoroquino-
lones), as well as compounds with high usage in the
Netherlands (tetracyclines and penicillins), see Table 1. The
workshop also considered criteria for the evaluation of sur-
veillance programs [5], and selected the following as most
important for the summary index on AMR:
 Continuity (C): Are data collected continuously and
in the same way from 2009 to 2013, and will the
system be continued in future?
Fig. 1 Antimicrobial veterinary medicinal product sales the Netherlands, 1999–2014 in kg (thousands). Published with permission of the Netherlands
Veterinary Medicine Authority [1]
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 Representativeness (R): Are the detected cases
representative for the target population (healthy
animals)?
 Simplicity (E): Have procedures and data collection
been restricted to the necessary minimum, and is
there a legal basis?
 Data quality (D): Are the data accurate and
complete, i.e. are the analyses carried out by
accredited laboratories using harmonized protocols?
 Sensitivity (S): Is the sample size sufficient to
demonstrate trends (i.e. > = 20 isolates per serovar
of species per year).
An evaluation of existing AMR monitoring in the
Netherlands is presented in Table 2. Based on this
evaluation, it was decided to base the AMR index on
monitoring of resistance in (commensal) E. coli in four
species of food animals (broiler chickens, pigs, veal calves
and dairy cattle) against four antimicrobial agents (Table 1).
Monitoring of AMR in commensal E. coli in food animals
The annual monitoring of AMR was performed accord-
ing to guidelines of the European Food Safety Authority
[3] and regulations of the European Union [6] and is
described in more detail below.
Sampling
Each year, a minimum of 300 samples per animal species
from broiler chickens, fattening pigs, veal calves and
dairy cows were collected randomly by the Dutch Food
and Consumer Safety Authority from a unique
epidemiological unit (farm, flock or group of animals).
Samples were stored at 2–8 °C and sent to CVI within
48 h after collection for further analysis. Caecal samples
of broiler chickens and faecal (or caecal)1 samples of
fattening pigs were obtained at slaughter during the
whole period of the monitoring. Pooled faecal samples
of veal calves were collected at farms until the end of
2011 and from 2012 and onwards individual faecal (or
caecal)1 samples were taken at slaughterhouses. Faecal
samples of dairy cows were collected at slaughter (in
2010 and 2011) or as pooled or individual samples at
farms (in 2009 and from 2012 onwards). The number of
samples tested annually was sufficient to obtain more
than 250 E. coli isolates per animal species per year
which is in compliance with EFSA guidelines (minimum
of 170 isolates per animal species). According to the
EFSA guidelines, this sample size allows to detect a
change of 15% in the situation of widespread resistance
(50% proportion of resistance) and to detect an increase
of 5% in the situation of few pre-existing resistant
isolates (0.1% proportion of resistance). The total set of
selected isolates is intended to represent the E. coli
population of each animal species of the entire country
in a given year, and does not provide information on
other factors such as seasonality and spatial variation.
Isolation, identification and susceptibility testing of E. Coli
Samples were processed in the laboratory on the day of
arrival. From each sample, a 10% w/v suspension was
prepared in peptone-glycerol medium. Suspensions were
stored at −20 °C in labelled aliquots of 3 ml each pend-
ing analysis. On each test day, batches of suspensions
were taken from the freezer and thawed at room
temperature. Subsequently, 10 μl of each suspension was
inoculated directly on MacConkey agar according to
EFSA guidelines. MacConkey agar plates were incubated
aerobically 16–20 h at 37 °C. The next day, one (red-
purple) colony typical for E. coli, was randomly picked
from the MacConkey agar plate and pure cultured on a
blood agar plate. Blood agar plates were incubated
Table 1 Selection of the most relevant combinations of micro-






Quinolones Ciprofloxacin X X X
Cephalosporines Cefotaxime X – X
Macrolides Erythromycin – X –
Tetracyclines Tetracycline X X X
Penicillins Ampicillin X X X
Clinically important antimicrobial agents are printed in bold, high usage
compounds in bold italics
Table 2 Evaluation of monitoring of AMR in the Netherlands for












Quinolones Ciprofloxacin C-EDS C-EDS C-EDS – C-EDS
Cephalosporins
Cefotaxime C-EDS C-EDS C-EDS – C-EDS
Tetracyclins Tetracycline C-EDS C-EDS C-EDS – C-EDS
Penicillins Ampicillin C-EDS C-EDS C-EDS – C-EDS
Campylobacter spp.
Quinolones Ciprofloxacin CREDS – -REDS -REDS -REDS
Cephalosporins
Cefotaxime CREDS – -REDS -REDS -REDS
Tetracyclins Tetracycline CREDS – -REDS -REDS -REDS
Penicillins Ampicillin CREDS – -REDS -REDS -REDS
E. coli
Quinolones Ciprofloxacin CREDS – CREDS CREDS CREDS
Cephalosporins
Cefotaxime CREDS – CREDS CREDS CREDS
Tetracyclins Tetracycline CREDS – CREDS CREDS CREDS
Penicillins Ampicillin CREDS – CREDS CREDS CREDS
1 C Continuity, R Representativeness, E Simplicity, D Data quality,
S Sensitivity
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aerobically for 16–20 h at 37 °C. Presumed E. coli
cultures were identified with MALDITOFF. Antimicro-
bial susceptibility testing of each confirmed E. coli isolate
against ciprofloxacin, cefotaxime, tetracycline and ampi-
cillin was performed according to ISO guidelines [7] on
commercially available antimicrobial panels in compli-
ance with EU regulations [6]. The interpretation of the
results was performed using epidemiological cut-off
values set by EUCAST.2
Data aggregation
Different methods of aggregating these data were
explored. Resistance to critically important antimicro-
bials was less prevalent than to high usage antimicro-
bials. A simple unweighted average trend will be
dominated by the pattern of resistance in high usage an-
timicrobials and was not preferred. The summary index
was therefore calculated for each animal species as a
weighted average over the four antibiotics, taking into





with wi the weight for antimicrobial agent i and pi,j the
prevalence of resistance in year j (2009–2014) against
antimicrobial agent i.
Weights were designed to reflect the clinical relevance
of the antimicrobial agents and were obtained by con-
joint analysis, involving medical microbiologists, epide-
miologists, AMR researchers, pharmacologists and
clinicians from primary, secondary and tertiary care,
who were asked to complete an online questionnaire.
The questionnaire was developed in the QuestBack®
software (www.questback.com/nl/).Respondents were
asked to make pairwise comparisons by answering the
following question:
“Consider two patients with the same condition and
history (immunological profile, underlying diseases,
previous use of antimicrobial agents etc.). Both
patients have a bloodstream infection with a (plasmid-
related) resistant Escherichia coli. One patient is
infected by a bacterium with resistance profile A and
the other patient with profile B. Which of these
patients has a higher probability of recovery?”
Of the 24 = 16 possible profiles, two (sensitive or resist-
ant against all four agents) were omitted from the pair-
wise comparisons because they were by definition most,
resp. least favourable and four were omitted as a com-
bination of resistance to cefotaxime and sensitivity to
ampicillin is never observed in practice. Furthermore, all
comparisons in which one resistance profile majorized
the other (e.g. resistant against both ciprofloxacin and
cefotaxime vs. resistant to only ciprofloxacin) were
excluded. This resulted in 24 pairwise comparisons per
expert. These were randomized both with regard to the
order of comparisons and which profile was defined as
A or B. To check consistency of the experts’ answers, a
random set of six comparisons was added at random
positions in the set, with assignment of resistance
profiles as A and B reversed. In this way, five random
sets were generated and each expert was randomly
assigned to one of these sets.
The outcomes were analysed using conditional logis-
tic regression in the statistical software R [8].The four
antibiotics were included in the model as explanatory
variables, while conditioning on the person-profile
combination. The resulting coefficients were trans-
formed into weights by dividing them by the sum of the
coefficients. Confidence intervals were obtained by
Monte Carlo simulation, where 1000 samples were
generated based on the estimated coefficients and their
covariance and assuming a multivariate Normal distri-
bution. Uncertainty in the prevalence of resistance
among E. coli isolates was quantified by a Beta distribu-
tion: pi, j~Beta(ri, j + 1, si, j + 1) where ri,j is the number
of resistant isolates against antimicrobial agent i in year
j, and si,j the number of sensitive isolates against
antimicrobial agent i in year j. The weighted average
was computed by Monte Carlo simulation to account
for both the uncertainty in clinical relevance and
prevalence of AMR, using @RISK (Palisade
Corporation, Ithaca, NY), an add-in to Microsoft Excel
(Redmond, WA).
Results
Figure 2 shows the monitoring results from 2009 to
2014 (detailed data in Annex 1). In general, resistance in
E. coli showed a tendency to decrease in all animal spe-
cies against all antimicrobials. In all animals except
broiler chickens, the prevalence of resistance was
Tet > Amp > Cip > Cef. In broiler chickens, a different
pattern was observed with Amp > Tet ≈ Cip > Cef.
Twenty-five experts were invited to participate in the
pairwise comparisons, and 17 on-line questionnaires
were completed (response rate 68%). Only the profession
of the non-responders was known, with an equal distri-
bution of non-responders among the four professional
groups. Of 17 respondents, 7 were medical microbiolo-
gists, 5 clinicians, 2 veterinarians, 1 pharmacologist, 1
AMR researcher/epidemiologist, and 1 a public health
physician. Of the 17 respondents, 15 provided consistent
answers for the pairwise comparisons that were included
twice (but in reverse order) in the set. This implies that
the null hypothesis of random completion of the ques-
tions was rejected (p < 0.0001).
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Table 3 shows the utility weights for the four antibi-
otics. The highest weights were given to ciprofloxacin
and cefotaxime (both 0.35) and these did not differ
significantly. The weight of ampicillin was significantly
lower (0.23) compared to these two, whereas tetracycline
was assigned the lowest weight (0.07).
These weights were combined with the AMR data to
calculate a weighted average resistance, see Fig. 3. The
graphs confirm a decreasing trend in the weighted resist-
ance prevalence (“AMR summary index”), but the time
trends differ between animal species. In broiler chickens,
the index was consistently higher than in the other ani-
mal species. A slight increase in the AMR index in 2010
was followed by a gradual decrease until 2014. The index
in 2014 was significantly lower than in 2010 and 2009
but continued to be at a relatively high level compared
to the other animal species. Resistance in fattening pigs
decreased steadily over the years and the index in 2014
was significantly different from 2009. Resistance levels in
veal calves were slightly higher than in pigs. In veal
calves, the index increased between 2009 and 2011,
followed by a decline in 2012 and stabilization in later
years. The index in 2012–2014 was significantly lower
than in 2009–2011. Resistance in dairy cows was signifi-
cantly lower than in any of the other animal species
tested, with a significant decrease of the index to very
low levels in 2010, compared to 2009 and then stabiliz-
ing at this low level (Fig. 3).
Discussion
Reducing AMR in food animals is a key policy objective
in many countries around the world to control the
spread and exposure of humans and animals to resistant
pathogens. In the Netherlands, the recent discovery of
significant reservoirs of antimicrobial-resistant patho-
gens such as methicillin-resistant Staphylococcus aureus
(MRSA) and extended spectrum beta-lactamase-
producing bacteria (ESBL) in farm animals, with poten-
tial public health implications, combined with an in-
creasing lack of confidence of the public in intensive
livestock industries, and discrepancy between the very
low antimicrobial use in humans and high use in ani-
mals, resulted in intensive collaboration between the
government, veterinary professional organizations and
important stakeholders within the livestock sector. A
combination of compulsory and voluntary actions with
Fig. 2 Resistance against antimicrobial agents in E. coli isolates from food animals in the Netherlands, 2009–2014
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clear reduction goals resulted in a 56% reduction in anti-
microbial use in farm animals [9]. This study shows that
active monitoring of resistance among commensal bac-
teria in food animals can inform about the impact of
such policies on AMR, and that detailed data can be
aggregated to summary indices that are meaningful for
policy makers. This aggregation included a novel
approach to weigh the observed prevalence against dif-
ferent antibiotics for their clinical relevance. We used a
pairwise ranking method to obtain weights of the differ-
ent antimicrobial agents for construction of a pooled
estimate. Expert’s answers were highly consistent, indi-
cating overall agreement between different professional
groups. The majority of respondents consisted of
medical microbiologists and clinicians, of which we
knew they were also involved in research. One of two
pharmacologists that were invited to participate,
responded. Group sizes were too small to allow formal
statistical evaluation of differences between respondent
groups.
The results suggest that the policy to reduce anti-
microbial usage in food animals was effective in redu-
cing the resistance of commensal bacteria. A recent
analysis of the association between antimicrobial usage
and acquired antimicrobial resistance in E. coli in the
Netherlands concluded that “drug use history and co-
selection of resistance are key elements for perpetuation
of resistance” Furthermore, it was concluded that “recent
Dutch policies aimed at reducing total use of antimicro-
bials have decreased E. coli resistance in the pig and veal
calf production sectors while the impact on the dairy
cattle and poultry sectors is less clear” [10].
Indicator or sentinel organisms such as E. coli are
included in EFSA based AMR-surveillance programs
because they are intrinsically susceptible to the antibi-
otics included in the test panel and they are present in
all samples, which facilitates proper randomization and
Table 3 Weights of antibiotics based on pairwise comparison of
resistance profiles





Fig. 3 Weighted average resistance (AMR index) against antimicrobial agents in E. coli isolates from food animals in the Netherlands, 2009–2014
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trend analysis. Therefore, trends in AMR-patterns
observed may more truly reflect the antibiotic use
patterns in the animals the strains are derived from. The
association of these patterns with those of food-borne
pathogens such as Salmonella is not one-in-one, given
the fact that Salmonella is not present in all animals and
all farms and in Salmonella trends should be analyzed
by serotype. Furthermore, trends in gram-positive
bacteria may differ from those in gram-negative bacteria.
Still, in the Netherlands, the trends observed in E. coli,
are predictive of those in food-borne pathogens [1].
The available monitoring data were not fully system-
atic and the sampling protocol changed over time, to
concur with EFSA guidelines that were published in
2012. Therefore, observed trends in AMR among bacteria
in food animals in the Netherlands need to be interpreted
with care. Nevertheless, our method allows for comprehen-
sive presentation of collected data to a lay public.
Conclusion
We demonstrate that high-dimensional data on surveil-
lance of antimicrobial resistance can be summarized in an
index for evaluating trends between and within food animal
species by a process involving decision makers and scien-
tists to select and weight the most relevant antibiotics.
Endnotes
1Due to the implementation of EU regulations faecal
samples of fattening pigs and veal calves were substituted
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